Published in Int J Pharm Investig on December 18, 2015
Choline availability alters embryonic development of the hippocampus and septum in the rat. Brain Res Dev Brain Res (1999) 1.90
Sintering of wax for controlling release from pellets. AAPS PharmSciTech (2007) 1.39
Perinatal choline influences brain structure and function. Nutr Rev (2006) 1.26
Dual fortification of salt with iodine and microencapsulated iron: a randomized, double-blind, controlled trial in Moroccan schoolchildren. Am J Clin Nutr (2003) 1.22
Choline availability modulates the expression of TGFbeta1 and cytoskeletal proteins in the hippocampus of developing rat brain. Neurochem Res (1998) 0.99
Formulation and evaluation of olanzapine matrix pellets for controlled release. Daru (2011) 0.95
Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol (2010) 0.92
Choline deficiency causes increased localization of transforming growth factor-beta1 signaling proteins and apoptosis in the rat liver. Pathobiology (1997) 0.89
Development and evaluation of diltiazem hydrochloride controlled-release pellets by fluid bed coating process. J Adv Pharm Technol Res (2013) 0.81
Hot-melt coating with lipid excipients. Int J Pharm (2012) 0.81
Formulation of immediate release pellets containing famotidine solid dispersions. Saudi Pharm J (2013) 0.81